News
Article
BioSpectra Opens Contract Manufacturing Facility
Author(s):
BioSpectra's Pennsylvania facility will manufacture biological buffers, pharmaceutical excipients, and laboratory reagents.
BioSpectra opened an FDA-registered facility in Bangor, Pennsylvania, US for contract-manufactured products for pharmaceutical, biopharmaceutical, and drug manufacturing markets.
BioSpectra provides custom cGMP purifications, acidifications, acid/base reactions, custom formulations, and particle manipulation backed by fully-documented regulatory support using ICHQ7 manufacturing systems. The company produces biological buffers, pharmaceutical excipients, and laboratory reagents.
Source: BioSpectra
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
